Lybocent

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	30-01-2026	1 d early	2026-00032238
30-06-2024	31-01-2025	31-01-2025	on the day	2025-00033313

Metric	This company	Sector median	Position in the sector
Solvency	22.6%	25.9%	better than 47% of 1080 sector peers
Net result	€8k	€7k	better than 52% of 1081 sector peers
Equity	€19k	€23k	better than 45% of 1083 sector peers
Gross operating margin	€13k	€64k	better than 19% of 1077 sector peers
Total assets	€83k	€109k	better than 40% of 1080 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€83k
Fixed assets	21/28	€2k
Tangible fixed assets	22/27	€2k
Current assets	29/58	€81k
Amounts receivable within one year	40/41	€78k
Cash & bank	54/58	€3k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€83k
Equity	10/15	€19k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€14k
Amounts payable	17/49	€64k
Amounts payable within one year	42/48	€64k
Trade debts payable within one year	44	€17k
Income statement
Gross operating margin	9900	€13k
Operating result	9901	€12k
Financial income	75	€0
Financial charges	65	€50
Result before taxes	9903	€12k
Income taxes	67/77	€4k
Net result for the period	9904	€8k
Result to be appropriated	9905	€8k

Summary